HomeInsightsStock Comparison

Alkem Laboratories Ltd vs Gufic Biosciences Ltd Stock Comparison

Alkem Laboratories Ltd vs Gufic Biosciences Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Alkem Laboratories Ltd is ₹ 5015 as of 16 Jul 13:15.
  • The P/E Ratio of Alkem Laboratories Ltd changed from 32.9 on March 2024 to 41.3 on March 2023 . This represents a CAGR of 4.65% over 5 yearsThe P/E Ratio of Gufic BioSciences Ltd changed from 33 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Alkem Laboratories Ltd changed from ₹ 59067 crore on March 2024 to ₹ 40626 crore on March 2023 . This represents a CAGR of -7.21% over 5 yearsThe Market Cap of Gufic BioSciences Ltd changed from ₹ 2839 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 5 years.
  • The revenue of Alkem Laboratories Ltd for the Mar '25 is ₹ 3289 crore as compare to the Dec '24 revenue of ₹ 3467 crore. This represent the decline of -5.12% The revenue of Gufic BioSciences Ltd for the Mar '25 is ₹ 205.41 crore as compare to the Dec '24 revenue of ₹ 209.66 crore. This represent the decline of -2.03%.
  • The ebitda of Alkem Laboratories Ltd for the Mar '25 is ₹ 537.25 crore as compare to the Dec '24 ebitda of ₹ 852.38 crore. This represent the decline of -36.97% The ebitda of Gufic BioSciences Ltd for the Mar '25 is ₹ 26.77 crore as compare to the Dec '24 ebitda of ₹ 35.79 crore. This represent the decline of -25.2%.
  • The net profit of Alkem Laboratories Ltd changed from ₹ 287.81 crore to ₹ 323.01 crore over 8 quarters. This represents a CAGR of 5.94% The net profit of Gufic BioSciences Ltd changed from ₹ 20.62 crore to ₹ 7.72 crore over 8 quarters. This represents a CAGR of -38.81% .
  • The Dividend Payout of Alkem Laboratories Ltd changed from 23.64 % on March 2020 to 27.37 % on March 2024 . This represents a CAGR of 2.97% over 5 yearsThe Dividend Payout of Gufic BioSciences Ltd changed from 2.14 % on March 2020 to 1.16 % on March 2024 . This represents a CAGR of -11.53% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alkem Laboratories Ltd

  • Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations.
  • The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
  • The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets.
  • With a portfolio of more than 800 brands in India, Alkem is ranked the fifth largest pharmaceutical company in India in terms of domestic sales.
  • The company also has presence in more than 40 international markets, with the United States being its key focus market. Alkem Laboratories Limited was incorporated as a private limited company on August 8, 1973 in Patna and subsequently became a deemed public limited company on October 26, 1988.

About Gufic BioSciences Ltd

  • Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients.
  • Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network.
  • The Company is ranked among the top 100 pharmaceutical companies in India. Gufic is a leading manufacturer of lyophilized injections in India, with a state-of-the-art automated lyophilization plant located in Navsari, Gujarat.
  • The Company was incorporated in July, 1984.
  • The recent addition of the Indore manufacturing facility has further solidified Gufic's position as one of the world's largest producers of lyophilized injections.

Alkem Laboratories Ltd News Hub

News

Alkem Laboratories Ltd rises for third consecutive session

Alkem Laboratories Ltd gained for a third straight session today. The stock is quoting at ...

Read more

15 Jul 2025 13:05

News

Alkem Laboratories Ltd up for third straight session

Alkem Laboratories Ltd is up for a third straight session today. The stock is quoting at R...

Read more

10 Jun 2025 13:05

News

Volumes spurt at Alkem Laboratories Ltd counter

Tata Technologies Ltd, Aditya Birla Fashion & Retail Ltd, Kaynes Technology India Ltd, Sun...

Read more

04 Jun 2025 11:00

News

Alkem Laboratories to conduct AGM

Alkem Laboratories announced that the 51th Annual General Meeting(AGM) of the company will...

Read more

29 May 2025 17:45

News

Board of Alkem Laboratories recommends final dividend

Alkem Laboratories announced that the Board of Directors of the Company at its meeting hel...

Read more

29 May 2025 17:27

News

Alkem Laboratories to discuss results

Alkem Laboratories will hold a meeting of the Board of Directors of the Company on 29 May ...

Read more

17 May 2025 15:23

Gufic BioSciences Ltd News Hub

News

Gufic BioSciences appoints senior management personnel

Gufic BioSciences has appointed Rajesh Kaul as Senior President ' Sparsh Cluster, Senior M...

Read more

02 Jul 2025 18:34

News

Board of Gufic BioSciences recommends final dividend

Gufic BioSciences announced that the Board of Directors of the Company at its meeting held...

Read more

30 May 2025 20:18

News

Gufic BioSciences to announce Quarterly Result

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 30 May 2...

Read more

24 May 2025 18:18

News

Gufic BioSciences to announce Quarterly Result

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 14 Febru...

Read more

08 Feb 2025 14:21

News

Gufic Biosciences tumbles after Q2 PAT drops 6% YoY to Rs 22 cr

Profit before tax (PBT) fell 5.46% YoY to Rs 29.25 crore during the quarter. Total expense...

Read more

18 Nov 2024 11:09

News

Gufic Biosciences Q2 PAT drops 6% YoY to Rs 22 cr

Profit before tax (PBT) fell 5.46% YoY to Rs 29.25 crore during the quarter. Total expense...

Read more

15 Nov 2024 12:29

SWOT Analysis Of Alkem Laboratories Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Gufic BioSciences Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Alkem Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Gufic BioSciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alkem Laboratories Ltd and Gufic BioSciences Ltd

Which company has a larger market capitalization, Alkem Laboratories Ltd or Gufic BioSciences Ltd?

Market cap of Alkem Laboratories Ltd is 58,986 Cr while Market cap of Gufic BioSciences Ltd is 3,710 Cr

What are the key factors driving the stock performance of Alkem Laboratories Ltd and Gufic BioSciences Ltd?

The stock performance of Alkem Laboratories Ltd and Gufic BioSciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alkem Laboratories Ltd and Gufic BioSciences Ltd?

As of July 16, 2025, the Alkem Laboratories Ltd stock price is INR ₹4933.45. On the other hand, Gufic BioSciences Ltd stock price is INR ₹370.0.

How do dividend payouts of Alkem Laboratories Ltd and Gufic BioSciences Ltd compare?

To compare the dividend payouts of Alkem Laboratories Ltd and Gufic BioSciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions